Bristol-Myers Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Clinton NY United States (1887)
Status: Acquired by Bristol-Myers Squibb (1989)

Organization Overview

First Clinical Trial
2007
NCT00390936
First Marketed Drug
1945
tubocurarine (curare)
First NDA Approval
1945
tubocurarine (curare)
Last Known Activity
2007

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

BRISTOL | Bristol Myers | BRISTOL-MYERS